Corveus Medical GTM brain

category

market profile

• text: Some heart failure patients remain symptomatic and experience hospitalization despite guideline-directed treatment.
• text: Splanchnic nerve ablation is an investigational approach; results from other devices cannot establish efficacy for Corveus.

personas

• title: Heart failure cardiologist
  pains:

  • Patients remain symptomatic despite medical therapy
  • Needs strong safety and outcome evidence before adopting a new intervention
• title: Interventional cardiologist
  pains:

  • Targeting the nerve must minimize damage to surrounding tissue
  • Needs a reproducible procedure and evidence of treatment confirmation
• title: Hospital cardiovascular research director
  pains:

  • Must identify suitable trial participants and clinical investigators
  • Needs a regulatory and evidence plan before introducing a new procedure

icp

• text: Academic medical centers and hospitals with heart failure specialists and interventional cardiology capability, as potential research partners.
• text: Clinical programs treating patients with persistent symptoms despite standard therapy and interested in device-based approaches.

message pillars

• text: Address a widespread heart failure burden.
• text: Develop a minimally invasive catheter-based intervention.
• text: Focus on easing the burden of chronic disease.

objections

• objection: Is the specific device clinically proven and authorized?
  response: Request current device-specific study results, trial status, adverse events and regulatory documentation; public evidence remains limited.
• objection: Can the procedure avoid collateral tissue damage?
  response: Review the device's targeting and preclinical safety evidence before considering participation in research.
• objection: How would a hospital pay for it?
  response: Ask for an updated regulatory and reimbursement roadmap; public pricing and reimbursement are not established here.

competitors

• name: Axon Therapies
  why: Investigates a catheter-based splanchnic nerve ablation approach for heart failure.
• name: CVRx
  why: Offers a different neuromodulation approach for selected heart failure patients.
• name: V-Wave
  why: Develops an interatrial shunt, an alternative device approach to heart failure.

influencers

• name: Tyler Melton
  url: https://www.corveusmedical.com/
  why: CEO and cofounder presenting the device and its clinical goals.

keywords

• heart failure catheter nerve ablation
• splanchnic nerve ablation heart failure
• interventional heart failure device
• chronic heart failure neuromodulation
• catheter treatment heart failure
• heart failure congestion device

voice

• Clinical
• Patient-centered
• Research-oriented

signals

• text: A heart failure center seeks clinical studies for patients with persistent symptoms despite standard therapy.
• text: An interventional program is investigating splanchnic nerve modulation or other device-based heart failure approaches.

pricing

motion

channels

• Website contact
• Medical innovation events

confidence

Founders

• name: Tyler Melton
  title: Founder
  role: Founder
  bio: Medical Device | Biomedical Engineering | Business Strategy